Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Lobular 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 3Ifosfamide 3Doxorubicin 3Vincristine 2Neoadjuvant Therapy 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Carboplatin 2romidepsin 1cixutumumab 1Temozolomide 1Sorafenib 1Peripheral Blood Stem Cell Transplantation 1Molecular Diagnostic Techniques 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Filgrastim 1Brachytherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Hemangiopericytoma, Malignant × Molecular Diagnostic Techniques × Clear all
NCT00900211 2013-08-26

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

National Cancer Institute (NCI)

Unknown
400 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡